Performance of TMO Thermo Fisher Scientific | 7.9% in 12m
Compare TMO with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Thermo Fisher Scientific with its related Sector/Index XLV
Performance Duell TMO vs XLV
TimeFrame | TMO | XLV |
---|---|---|
1 Day | 0.33% | 0.03% |
1 Week | 5.29% | 0.73% |
1 Month | 0.84% | -3.99% |
3 Months | 4.87% | 0.86% |
6 Months | 30.5% | 12.64% |
12 Months | 7.88% | 8.01% |
YTD | 5.48% | 1.21% |
Rel. Perf. 1m | 0.38 | |
Rel. Perf. 3m | 0.85 | |
Rel. Perf. 6m | 1.42 | |
Rel. Perf. 12m | -0.22 |
Is Thermo Fisher Scientific a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Thermo Fisher Scientific (NYSE:TMO) is currently (April 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.10 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TMO as of April 2024 is 562.06. This means that TMO is currently overvalued and has a potential downside of -2.01% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TMO as of April 2024 is 562.06. This means that TMO is currently overvalued and has a potential downside of -2.01% (Sold with Premium).
Is TMO a buy, sell or hold?
- Strong Buy: 12
- Buy: 6
- Hold: 10
- Sell: 0
- Strong Sell: 0
Values above 0%: TMO is performing better - Values below 0%: TMO is underperforming
Compare TMO with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 2.64% | 2.87% | 6.41% | -19.64% |
US NASDAQ 100 | QQQ | 1.35% | 3.62% | 4.59% | -31.24% |
US Dow Jones Industrial 30 | DIA | 4.63% | 3.47% | 12.78% | -9.17% |
German DAX 40 | DBXD | 2.95% | 2.19% | 7.45% | -6.39% |
UK FTSE 100 | ISFU | 1.78% | -0.71% | 14.76% | 0.37% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.38% | -0.48% | 28.01% | 19.67% |
Hongkong Hang Seng | HSI | -3.42% | -1.14% | 32.20% | 26.35% |
Japan Nikkei 225 | EXX7 | 5.36% | 8.85% | 13.41% | -9.91% |
India NIFTY 50 | INDA | 3.36% | -2.23% | 8.05% | -22.32% |
Brasil Bovespa | EWZ | 2.69% | 3.07% | 23.38% | -14.08% |
TMO Thermo Fisher Scientific vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.48% | 2.39% | 3.32% | -36.17% |
Consumer Discretionary | XLY | 1.67% | 4.37% | 11.19% | -15.50% |
Consumer Staples | XLP | 3.75% | 0.68% | 16.82% | 5.75% |
Energy | XLE | 4.48% | -2.62% | 18.11% | -10.70% |
Financial | XLF | 4.20% | 2.24% | 1.94% | -20.91% |
Health Care | XLV | 4.56% | 4.83% | 17.85% | -0.13% |
Industrial | XLI | 3.47% | 1.88% | 3.34% | -20.54% |
Materials | XLB | 4.66% | 2.82% | 9.83% | -8.43% |
Real Estate | XLRE | 3.67% | 5.67% | 17.63% | 4.26% |
Technology | XLK | 1.50% | 4.61% | 5.26% | -30.00% |
Utilities | XLU | 4.13% | -3.51% | 17.95% | 7.58% |
Aerospace & Defense | XAR | 2.36% | 2.59% | 10.69% | -14.11% |
Biotech | XBI | 4.49% | 10.77% | 4.31% | 2.64% |
Homebuilder | XHB | 1.74% | 5.97% | -18.28% | -46.86% |
Retail | XRT | 2.41% | 5.55% | 4.71% | -14.49% |
Does Thermo Fisher Scientific outperform its market, is TMO a Sector Leader?
No, over the last 12 months Thermo Fisher Scientific (TMO) made 7.88%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.01%.
Over the last 3 months TMO made 4.87%, while XLV made 0.86%.
No, over the last 12 months Thermo Fisher Scientific (TMO) made 7.88%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.01%.
Over the last 3 months TMO made 4.87%, while XLV made 0.86%.
Period | TMO | XLV | S&P 500 |
---|---|---|---|
1 Month | 0.84% | -3.99% | -2.03% |
3 Months | 4.87% | 0.86% | 4.60% |
12 Months | 7.88% | 8.01% | 27.52% |